More importantly, we found that the CCL2 gradient detected in primary NSCLC as well as in NSCLC brain metastases can be exploited to promote efficient migration of B7-H3.CAR-T cells through the BBB and to enhance antitumor effects when these cells overexpress CCR2b. This evidence concerns the gene CCL2 and non-small cell lung carcinoma.